Enhancing the Translational Confidence of Models Based Research
December 4 - 6, 2018
Tumour Microenvironment, Heterogeneity, and Clinically Relevant Models
Wednesday December 5th, 08:30-08:55am
Clinically relevant preclinical models are needed to better understand cancer progression and to correctly identify patient responder subgroups. Learn more about the development of 3D systems and PDX modelling to meet this need, and to enhance the translational success of oncology drug development. Find out how to adopt the right model for the right study across oncology therapeutics.